The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome
Disease Models & Mechanisms · 2024
DOI: 10.1242/dmm.050762 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2024. Verfasst von Tara A Gleeson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Interleukin-18, Inflammasomes, Disease Models, Animal. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, The University of Manchester, Swedish Orphan Biovitrum.
Abstract (Originalsprache)
Hyperinflammatory disease is associated with an aberrant immune response resulting in cytokine storm. One such instance of hyperinflammatory disease is known as macrophage activation syndrome (MAS). The pathology of MAS can be characterised by significantly elevated serum levels of interleukin-18 (IL-18) and interferon gamma (IFNγ). Given the role for IL-18 in MAS, we sought to establish the role of inflammasomes in the disease process. Using a murine model of CpG-oligonucleotide-induced MAS, we discovered that the expression of the NLRP3 inflammasome was increased and correlated with IL-18 production. Inhibition of the NLRP3 inflammasome or the downstream caspase-1 prevented MAS-mediated upregulation of IL-18 in the plasma but, interestingly, did not alleviate key features of hyperinflammatory disease including hyperferritinaemia and splenomegaly. Furthermore blockade of IL-1 receptor with its antagonist IL-1Ra did not prevent the development of CpG-induced MAS, despite being clinically effective in the treatment of MAS. These data demonstrate that, during the development of MAS, the NLRP3 inflammasome was essential for the elevation in plasma IL-18 – a key cytokine in clinical cases of MAS – but was not a driving factor in the pathogenesis of CpG-induced MAS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK.
- Geoffrey Jefferson Brain Research Centre, The Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester M6 8HD, UK.
- Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester M13 9PL, UK.
- Swedish Orphan Biovitrum (Sobi), AB, Stockholm 112 76, Sweden.
ORCID-Profile: Tara A Gleeson, Christina Kaiser, Catherine B Lawrence, David Brough, Stuart M Allan, Jack P Green
Förderung
- Medical Research Council
- The University of Manchester
- Swedish Orphan Biovitrum
Zitieren
APA
Gleeson, T. A., Kaiser, C., Lawrence, C. B., Brough, D., Allan, S. M., & Green, J. P. (2024). The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.050762
Vancouver
Gleeson TA, Kaiser C, Lawrence CB, Brough D, Allan SM, Green JP. The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome. Disease Models & Mechanisms. 2024. doi:10.1242/dmm.050762
BibTeX
@article{Gleeson2024,
author = {Gleeson, Tara A and Kaiser, Christina and Lawrence, Catherine B and Brough, David and Allan, Stuart M and Green, Jack P},
title = {The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome},
journal = {Disease Models & Mechanisms},
year = {2024},
doi = {10.1242/dmm.050762}
}
EUVIMED